Objective: This study aims to elucidate the mechanism by which the microRNA miR-30b-5p inhibits the proliferation, invasion, and migration of osteosarcoma cells while inducing apoptosis through the regulation of P4HA2. Methods: The MG63 osteosarcoma cell line was transfected with miR-NC and miR-30b-5p mimics to establish negative control and miR-30b-5p up-regulated expression models. Subsequently, various assays were conducted, including the CCK8 assay, Transwell assay, flow cytometry, dual luciferase reporter assay, real-time PCR (RT-PCR), and Western blot analysis. Results: Following the transfection of MG63 cells with miR-30b-5p mimics, the expression of miR-30b-5p was significantly up-regulated compared to the control group (t = 77.53, p = 0.0002). After transfecting the cells with miR-NC and miR-30b-5p mimics for 24, 48, and 72 hours, the CCK8 assay results indicated a marked reduction in proliferative ability relative to the control group (24 h: t = 16, P < 0.001; 48 h: t = 5.318, P < 0.0001; 72 h: t = 10.58, P < 0.0001). Additionally, the Transwell assay results demonstrated that the invasive ability of cells in the miR-30b-5p mimics group was significantly lower than that in the miR-NC group (t = 8.92, P < 0.0001), and the migration level was also significantly reduced (t = 23, P < 0.0001). Flow cytometry analysis revealed that the apoptosis level of MG63 cells in the miR-30b-5p mimics group was significantly increased compared to the miR-NC group (t = 14.06, P = 0.0001). Dual-luciferase reporter assay demonstrated that P4HA2 is a direct target molecule of miR-30b-5p. Furthermore, RT-PCR and Western blot experiments confirmed that the expression of P4HA2 in osteosarcoma cells was significantly down-regulated at both the mRNA and protein levels following miR-30b-5p transfection. In contrast, the expression of the pro-apoptotic protein BAX was elevated, while the expression of the anti-apoptotic protein BCL-2 was decreased. Conclusion: miR-30b-5p plays a role in inhibiting the proliferation, invasion, and migration of osteosarcoma cells while also inducing apoptosis by targeting and down-regulating P4HA2 expression. However, the experiments were constrained, as they were validated in a single cell line and lacked the most direct evidence obtained through “functional recovery assays. experiments”.
Tian, H., Cao, J., Li, B., Nice, E.C., Mao, H., Zhang, Y., et al. (2023) Managing the Immune Microenvironment of Osteosarcoma: The Outlook for Osteosarcoma Treatment. Bone Research, 11, 1 Article No. 1. https://doi.org/10.1038/s41413-023-00246-z
[3]
Lei, T., Qian, H., Lei, P. and Hu, Y. (2021) Ferroptosis-Related Gene Signature Associates with Immunity and Predicts Prognosis Accurately in Patients with Osteosarcoma. Cancer Science, 112, 4785-4798. https://doi.org/10.1111/cas.15131
[4]
He, B., Zhao, Z., Cai, Q., Zhang, Y., Zhang, P., Shi, S., et al. (2020) miRNA-Based Biomarkers, Therapies, and Resistance in Cancer. International Journal of Biological Sciences, 16, 2628-2647. https://doi.org/10.7150/ijbs.47203
[5]
Menon, A., Abd-Aziz, N., Khalid, K., Poh, C.L. and Naidu, R. (2022) miRNA: A Promising Therapeutic Target in Cancer. International Journal of Molecular Sciences, 23, Article No. 11502. https://doi.org/10.3390/ijms231911502
[6]
Wang, J., Pang, W., Zuo, Z., Zhang, W. and He, W. (2017) MicroRNA-520b Suppresses Proliferation, Migration, and Invasion of Spinal Osteosarcoma Cells via Downregulation of Frizzled-8. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, 25, 1297-1304. https://doi.org/10.3727/096504017x14873430389189
[7]
Xu, Y., Yao, T., Huang, K., Liu, G., Huang, Y., Gao, J., et al. (2020) Circular RNA circTUBGCP3 Is Up-Regulated and Promotes Cell Proliferation, Migration and Survivability via Sponge MiR-30b in Osteosarcoma. OncoTargets and Therapy, 13, 3729-3737. https://doi.org/10.2147/ott.s245366
[8]
Zhou, Y., Yang, D., Yang, Q., Lv, X., Huang, W., Zhou, Z., et al. (2020) Single-Cell RNA Landscape of Intratumoral Heterogeneity and Immunosuppressive Microenvironment in Advanced Osteosarcoma. Nature Communications, 11, Article No. 6322. https://doi.org/10.1038/s41467-020-20059-6
[9]
Gill, J. and Gorlick, R. (2021) Advancing Therapy for Osteosarcoma. Nature Reviews Clinical Oncology, 18, 609-624. https://doi.org/10.1038/s41571-021-00519-8
[10]
Huang, Q., Liang, X., Ren, T., Huang, Y., Zhang, H., Yu, Y., et al. (2021) The Role of Tumor-Associated Macrophages in Osteosarcoma Progression—Therapeutic Implications. Cellular Oncology, 44, 525-539. https://doi.org/10.1007/s13402-021-00598-w
[11]
Lei, Y., Yan, W., Lin, Z., Liu, J., Tian, D. and Han, P. (2020) Comprehensive Analysis of Partial Epithelial Mesenchymal Transition-Related Genes in Hepatocellular Carcinoma. Journal of Cellular and Molecular Medicine, 25, 448-462. https://doi.org/10.1111/jcmm.16099
[12]
Lai, X., Schmitz, U. and Vera, J. (2022) The Role of MicroRNAs in Cancer Biology and Therapy from a Systems Biology Perspective. In: Advances in Experimental Medicine and Biology, Springer International Publishing, 1-22. https://doi.org/10.1007/978-3-031-08356-3_1
[13]
Xie, M., Lv, Y., Liu, Z., Zhang, J., Liang, C., Liao, X., et al. (2018) Identification and Validation of a Four-miRNA (miRNA-21-5p, miRNA-9-5p, miR-149-5p, and miRNA-30b-5p) Prognosis Signature in Clear Cell Renal Cell Carcinoma. Cancer Management and Research, 10, 5759-5766. https://doi.org/10.2147/cmar.s187109
[14]
Estevão-Pereira, H., Lobo, J., Salta, S., Amorim, M., Lopes, P., Cantante, M., et al. (2019) Overexpression of Circulating MiR-30b-5p Identifies Advanced Breast Cancer. Journal of Translational Medicine, 17, Article No. 435. https://doi.org/10.1186/s12967-019-02193-y
[15]
Chen, K., Wang, Q., Liu, X., Wang, F., Yang, Y. and Tian, X. (2022) Hypoxic Pancreatic Cancer Derived Exosomal miR-30b-5p Promotes Tumor Angiogenesis by Inhibiting GJA1 Expression. International Journal of Biological Sciences, 18, 1220-1237. https://doi.org/10.7150/ijbs.67675
[16]
Chen, H., Han, X., Sun, H., Xie, T. and Fan, X. (2024) Genomic Nursing Science Revealed the Prolyl 4-Hydroxylase Subunit Alpha 2 as a Significant Biomarker Involved in Osteosarcoma. Heliyon, 10, e27191. https://doi.org/10.1016/j.heliyon.2024.e27191